Corcept Therapeutics Ownership | Who Owns Corcept Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Corcept Therapeutics Ownership Summary


Corcept Therapeutics is owned by 84.27% institutional investors, 11.52% insiders, and 4.21% retail investors. Blackrock is the largest institutional shareholder, holding 16.09% of CORT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.72% of its assets in Corcept Therapeutics shares.

CORT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCorcept Therapeutics84.27%11.52%4.21%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock16.54M16.09%$537.36M
Blackrock funding, inc. /de15.68M15.17%$789.98M
Vanguard group9.55M9.29%$310.40M
Ingalls & snyder8.10M7.84%$408.15M
Renaissance6.91M6.72%$224.59M
Parallel advisors3.83M3.70%$192.98M
State street3.50M3.40%$113.69M
Dimensional fund advisors lp2.68M2.60%$86.95M
Novo2.41M2.35%$78.35M
Geode capital management2.28M2.22%$74.07M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ingalls & snyder8.10M16.01%$408.15M
Tanaka capital management100.28K7.71%$3.26M
Parallel advisors3.83M4.34%$192.98M
Novo2.41M3.93%$78.35M
Birchview capital, lp74.00K2.23%$2.40M
Synergy asset management462.41K1.73%$22.37M
S&t bank/pa199.79K1.65%$6.49M
Lisanti capital growth77.67K0.94%$3.91M
Fas wealth partners315.77K0.89%$10.26M
Burney co/473.82K0.84%$23.88M

Top Buyers

HolderShares% AssetsChange
Norges bank822.12K0.00%822.12K
Braun stacey associates296.39K0.56%296.39K
Synergy asset management462.41K1.73%262.50K
Fmr1.09M0.00%242.50K
Raymond james financial239.80K0.00%239.80K

Top Sellers

HolderShares% AssetsChange
Ikarian capital---994.50K
Man group829.94K0.07%-668.98K
Boston trust walden899.06K0.32%-614.91K
Kynam capital management, lp---585.90K
Bank of america corp /de/174.85K0.00%-498.50K

New Positions

HolderShares% AssetsChangeValue
Norges bank822.12K0.00%822.12K$26.71M
Braun stacey associates296.39K0.56%296.39K$14.94M
Raymond james financial239.80K0.00%239.80K$12.08M
Shelton capital management140.49K0.12%140.49K$4.56M
Van eck associates88.97K0.01%88.97K$4.48M

Sold Out

HolderChange
Claris advisors, llc / mo /-6.00
Mendota financial group-7.00
Nelson, van denburg & campbell wealth management group-16.00
Innealta capital-33.00
Harbor investment advisory-82.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202433511.67%87,110,973-2.41%841.12%17420.00%101-11.40%
Jun 30, 2024295-4.53%89,230,600-3.86%861.06%141-16.07%11328.41%
Mar 31, 20243097.29%92,808,6509.52%901.35%16819.15%88-7.37%
Dec 31, 202328812.50%84,743,8882.02%811.23%14115.57%953.26%
Sep 30, 20232569.87%83,063,0101.82%811.42%12237.08%92-5.15%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.99M5.72%13.61K
Vanguard Total Stock Mkt Idx Inv2.80M2.68%2.95K
Vanguard Small Cap Index2.27M2.16%27.69K
iShares Russell 2000 ETF2.20M2.10%-16.70K
Vanguard Institutional Extnd Mkt Idx Tr1.42M1.35%27.77K
Vanguard Small Cap Growth Index Inv1.29M1.23%54.09K
iShares S&P Small-Cap 600 Growth ETF863.49K0.82%-911.00
SPDR® Portfolio S&P 600™ Sm Cap ETF859.89K0.82%310.00
Fidelity Small Cap Index819.78K0.78%-5.93K
First Trust NYSE Arca Biotech ETF768.65K0.73%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 03, 2025Maduck Sean See RemarksSell$1.34M
Feb 03, 2025Lyon Joseph Douglas See RemarksSell$334.60K
Jan 10, 2025Swisher Daniel N JR-Sell$111.19K
Jan 02, 2025Maduck Sean See RemarksSell$1.01M
Jan 02, 2025Lyon Joseph Douglas See RemarksSell$251.95K

Insider Transactions Trends


DateBuySell
2025 Q1-6
2024 Q4-7
2024 Q3-8
2024 Q2-12
2024 Q1-8

CORT Ownership FAQ


Who Owns Corcept Therapeutics?

Corcept Therapeutics shareholders are primarily institutional investors at 84.27%, followed by 11.52% insiders and 4.21% retail investors. The average institutional ownership in Corcept Therapeutics's industry, Biotech Stocks , is 109.70%, which Corcept Therapeutics falls below.

Who owns the most shares of Corcept Therapeutics?

Corcept Therapeutics’s largest shareholders are Blackrock (16.54M shares, 16.09%), Blackrock funding, inc. /de (15.68M shares, 15.17%), and Vanguard group (9.55M shares, 9.29%). Together, they hold 40.55% of Corcept Therapeutics’s total shares outstanding.

Does Blackrock own Corcept Therapeutics?

Yes, BlackRock owns 16.09% of Corcept Therapeutics, totaling 16.54M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 537.36M$. In the last quarter, BlackRock decreased its holdings by -287K shares, a -1.71% change.

Who is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested?

Ingalls & snyder is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested, with 16.01% of its assets in 8.1M Corcept Therapeutics shares, valued at 408.15M$.

Who is the top mutual fund holder of Corcept Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Corcept Therapeutics shares, with 5.72% of its total shares outstanding invested in 5.99M Corcept Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools